DEC 02   

Monthly Return of Equity Issuer on Movements in Securities


NOV 11   

Commercial launch of Fortacin™ – a breakthrough treatment for premature ejaculation – now available in the UK and, from 2017, in Continental Europe


NOV 02   

Monthly Return of Equity Issuer on Movements in Securities


OCT 14   

Amended and Re-stated Memorandum and Articles of Association (Adopted by the Special Resolution passed on 19 August 2016 and effective on 12 October 2016)


OCT 14   

Next Day Disclosure Return (Equity issuer – changes in issued share capital and/or share buybacks)


OCT 14   

Effective date for capital reduction and free exchange of share certificates


OCT 13   

Result of court hearing on capital reduction


OCT 03   

Monthly Return of Equity Issuer on Movements in Securities


SEP 14   

Updated timetable for capital reduction


SEP 06   

List of Directors (1 September 2016)


SEP 02   

Monthly Return of Equity Issuer on Movements in Securities


SEP 01   

Resignation of Director


AUG 30   

Unaudited interim results for the six months ended 30 June 2016


AUG 19   

Poll results at Extraordinary General Meeting


AUG 18   

Notice of Board Meeting for unaudited interim results for the six months ended 30 June 2016


AUG 03   

Monthly Return of Equity Issuer on Movements in Securities


JUL 21   

Positive profit alert


JUL 20   

Notice of Extraordinary General Meeting


JUL 04   

Monthly Return of Equity Issuer on Movements in Securities


JUN 30   

Proposed capital reduction


JUN 13   

Discloseable transaction: Disposal of shares in Binary Limited


JUN 10   

Next Day Disclosure Return (Equity issuer – changes in issued share capital and/or share buybacks)


JUN 08   

Amended and Re-stated Memorandum and Articles of Association (Adopted by the Special Resolution passed on 30 May 2012) (Consolidated copy – 8 June 2016)


JUN 08   

Poll results at Extraordinary General Meeting


JUN 08   

Poll results at Annual General Meeting


JUN 02   

Monthly Return of Equity Issuer on Movements in Securities


MAY 19   

Update on commercialisation of PSD502: Approval of Type IB variation for reduced dose can


MAY 13   

Notice of Extraordinary General Meeting


MAY 11   

Completion of the First Tranche of the subscription of new shares in The Diabetic Boot Company Limited


MAY 03   

Proposed share consolidation and establishment of a new employee share option scheme


MAY 03   

Monthly Return of Equity Issuer on Movements in Securities


APR 27   

Notice of Annual General Meeting


APR 20   

Connected transaction: Further subscription of new shares in The Diabetic Boot Company Limited


APR 18   

Update on commercialisation of PSD502: Submission of Type IB variation for approval of reduced fill product


APR 05   

Monthly Return of Equity Issuer on Movements in Securities


APR 01   

Clarification on audited final results for the year ended 31 December 2015


MAR 30   

Audited final results for the year ended 31 December 2015


MAR 16   

Notice of Board Meeting for audited final results for the year ended 31 December 2015


MAR 09   

Next Day Disclosure Return (Equity issuer – changes in issued share capital and/or share buybacks)


MAR 09   

Recommended acquisition of Plethora Solutions Holdings plc (“Plethora”) by Regent Pacific Group Limited (“Regent Pacific”) (effected by means of a scheme of arrangement under Part 26 of the Companies Act 2006): Scheme becomes Effective


MAR 02   

Amended and Re-stated Memorandum and Articles of Association (Adopted by the Special Resolution passed on 30 May 2012) (Consolidated copy – 2 March 2016)


MAR 02   

Poll results at Extraordinary General Meeting and results of Plethora meetings


MAR 01   

Monthly Return of Equity Issuer on Movements in Securities


FEB 24   

Regent Pacific Group Limited (“Regent Pacific”) – Recommended acquisition of Plethora Solutions Holdings plc (“Plethora”): Letter of intent received from Capital for Enterprise Fund A L.P.


FEB 17   

Discloseable transaction: Disposal of shares in Endeavour Mining Corporation


FEB 04   

Notice of Extraordinary General Meeting


FEB 04   

Recommended offer for Plethora Solutions Holdings plc (“Plethora”) by Regent Pacific Group Limited (the “Company”) (to be effected by way of a scheme of arrangement under Part 26 of the Companies Act 2006): Publication and posting of the Very Substantial and Connected Acquisition Circular and the Scheme Document and Plethora’s current trading update


FEB 01   

Monthly Return of Equity Issuer on Movements in Securities


JAN 26   

Trading update


JAN 25   

Recommended offer for Plethora Solutions Holdings plc (“Plethora”) by Regent Pacific Group Limited (“Regent Pacific”) (to be effected by means of a Scheme of Arrangement under Part 26 of the Companies Act 2006): Timetable for posting the Scheme Document and Hong Kong Circular


JAN 20   

Regent Pacific Group Limited – Recommended offer for Plethora Solutions Holdings plc: Updated opening position disclosure


JAN 15   

Concert party - correction


JAN 11   

Recommended offer for Plethora Solutions Holdings plc (“Plethora”) by Regent Pacific Group Limited (“Regent Pacific”) (to be effected by means of a Scheme of Arrangement under Part 26 of the Companies Act 2006): Timetable for posting the Scheme Document and Hong Kong Circular


JAN 04   

Monthly Return of Equity Issuer on Movements in Securities